Clinical and pathogenetic substantiation of prevention of obstetrical complications in pregnant women with varicose disease

Abstract

The article presents the results of an improved method of antenatal surveillance of pregnant women with varicose disease which included the national medical drug that is a combination of 50 mg hesperidin and 450 mg diosmin (Normoven, PC «Kyiv Vitamin Factory»). Patients and methods. The study involved 49 pregnant women with varicose veins, which were divided into the basic and comparative group depending on the received treatment. The clinical and functional parameters, laboratory and instrumental methods were studied. The control group consisted of 23 pregnant women without varicose veins. Results. The absence of progression of clinical symptoms of the disease in 87.5% of pregnant women with varicose veins and improvement of the hemostatic parameters reflects the effectiveness of this therapy for the correction of the rheological properties of blood. The inclusion of hesperidin and diosmin to the complex therapy in pregnant women allowed to decrease the percentage of progression of changes in the venous system of the lower extremities almost twice. The normalization of processes of biosynthesis placental hormones in pregnant women shows the feasibility of using the drug with the systemic effects. The increase of the amplitude of instantaneous oscillations and the amplitude and duration of accelerations (p<0.05) according to the cardiotocographical observation indicates in favor of improving the state of the fetus in pregnant women. Conclusions. The inclusion of diosmin and hesperidin to the complex treatment of varicose veins in pregnant women is pathogenetically justified as it improves the degree of clinical manifestations of disease, hemostatic parameters , hormonal function of the placenta and fetus state. Key words: pregnancy, varicose veins, placental hormones, hemostatic parameters, hesperidin, diosmin.